Nitric oxide (NO) is a potent vasodilator and it can be generated by the ruthenium complex cis-[Ru(Hdcbpy À ) 2 (Cl)(NO À 2 )] (DCBPY). The present study aimed to investigate the NO specie generated and to characterize the cellular mechanisms involved on the vasodilatation induced by DCBPY. It was found that at pH 7.4 and 9.4, the NO + coordinated to ruthenium (Ru-NO
Introduction
Nitric oxide (NO) is a simple diatomic molecule that has been shown to participate in many important biological events, including vascular smooth muscle relaxation [1, 2] , inhibition of smooth muscle proliferation, and platelet aggregation [4] . The vascular relaxation induced by NO mainly involves the activation of soluble guanylyl cyclase (sGC) enzyme with production of cyclic guanosine-3 0 ,5 0 -monophosphate (cGMP) [4] . NO can also prompt vascular relaxation by an independent cGMP pathway, via direct activation of K + channels [5, 6] . Several studies have suggested that the mechanism of vascular relaxation varies for different NO donors, mainly in terms of the degree of activation of sGC and/or activation of K + channels [7, 8] .
NO is highly reactive molecule that reacts with a range of biomolecules, including metal center, thiols, superoxide and others, conferring to NO a short half-life in physiological conditions [9] . Basal NO synthesis; i.e., generation of NO at low concentration, is necessary to establish homeostasis of the cardiovascular system [3] . Decreased NO bioavailability has been described in cardiovascular disorders, such as hypertension and coronary disease [3] . Therefore, the use of NO donors could be a therapeutic alternative to NO failure.
Organic nitrates (e.g., Nitroglicerin, TNG) as well as inorganic nitrates (e.g., sodium nitroprusside, SNP) have been employed in the treatment of various cardiovascular disorders. However have undesirable side effects [10] . Continuous exposure to TNG leads to the development of nitrate tolerance [10] and endothelial dysfunction [11] . High doses of SNP or its prolonged use has been associated with endothelial dysfunction [13] , as well as accumulation of cyanide and the metabolite thiocyanate [12] . Therefore, the design of new NO donors with better pharmacological properties is highly desirable.
Macrocyclic ruthenium compounds have been investigated as NO donors [14] [15] [16] [17] and they have not displayed any toxic effects. These compounds have been found to induce vasodilatation in physiological conditions [17] [18] [19] and reduce blood pressure in hypertensive animals [20] . The configurations of the ruthenium ion are very useful due to their rich and versatile redox chemistry, in addition to their favorable thermodynamic and kinetic properties. However, there is a limiting factor in physiological conditions, namely the tendency of the NO coordinated to ruthenium (Ru-NO + ) to undergo electrophilic attack by hydroxide or water, which results in the production of Ru-NO À 2 nitro analog species [21] . Despite the formation of the latter species, some studies have shown that it can generate NO [22, 23] . Several works have reported mechanisms of in vivo conversion of NO À 2 to NO by non-enzymatic disproportionation at low pH [24] , xanthine oxidoreductase [25] , deoxyhemoglobin [26] , myoglobin [27] , among others. In this context, the present study aimed to investigate the NO specie generated and to characterize the cellular mechanisms involved on the vasodilatation induced by the new ruthenium complex cis-[Ru(H-dcbpy (Fig. 1A) , which can generate NO.
Methods

Synthesis of cis-[Ru(H-dcbpy
The cis-[Ru(H-dcbpy À ) 2 (Cl)(NO)] (DCBPY) complex was prepared as described by Cicillini et al. [28] 
Chemical studies for the DCBPY complex
The ultraviolet-visible (UV-Vis) spectra were recorded on a Hitachi U-3501 spectrophotometer. In all the experiments, the solution was kept at 37°C and phosphate buffer, namely at pH 5.4, pH 7.4, or pH 9.4. pH measurements were accomplished by means of a DM-20 pH meter (Digimed). were killed under anesthesia, and the thoracic aortas were isolated, cleaned of adherent connective tissues, and cut into rings with 4 mm length. The endothelium was mechanically removed by gently rolling the lumen of the vessel on a thin wire. The aortic rings were placed between two stainless-steel stirrups and connected to an isometric force transducer (Letica Scientific Instruments; Barcelona, Spain), to measure tension in the vessels. The rings were settled in a 10 mL organ chamber containing Krebs solution, which was maintained at pH 7.4 gassed with 95% O 2 and 5% CO 2 at 37°C. The rings were initially stretched to a basal tension of 1.5 g and were then allowed to equilibrate for 60 min.
Endothelial integrity was qualitatively assessed by the degree of relaxation induced by 1 lmol/L acetylcholine in the presence of contractile tone prompted by phenylephrine (0.1 lmol/L). In order to avoid interference of the endothelium factors, denuded aortas were employed. Therefore, the aortic rings were discarded if there was any degree of relaxation. The potency (pD 2 , which is the negative logarithm of the molar concentration producing the half maximum relaxant effect) and the maximum relaxant effect (ME, in percentage of relaxation) were evaluated. Concentration-effect curves for DCBPY, sodium nitruprusside (SNP), and sodium nitrite (NITRITE) were constructed for aortic rings pre-contracted with phenylephrine. In some experiments, the aortic rings were incubated for 30 min with either the sGC inhibitor 1H- ( Prior to its use, the compound DCBPY was prepared in phosphate buffer pH 7.4 and kept at 37°C for 180 min. This was done in order to avoid different configurations of the compound DCBPY, and ensure the presence of the configuration Ru-NO À 2 only. In some experiments, the compound DCBPY was solubilized at pH 5.4 or pH 9.4 ( Fig. 1C and D) .
Confocal microscopy
The confocal microscopy experiments were performed as described by Rodrigues et al. [29] . Rats were killed by decapitation, and the thoracic aortas were isolated and dissected. The endothelium was mechanically removed by gently rolling the lumen of the vessel on a thin wire. Cross sections of aortic rings (100-150 lm thick) were placed vertically on glass coverslips covered with poly-L-Lysine, in Hanks solution. The slice preparations were kept for 60 min in a humidified incubator at 37°C and gassed with 5% CO 2 .
To quantify the cytosolic Ca Slice preparations were imaged in Hanks buffer at pH 7.4, by using a confocal scanning laser microscope (Leica TCS-SP5). Fluo-3AM fluorescence was excited with the 488 nm line of an argon ion laser, and the emitted fluorescence was measured at 510 nm. DAF-2/DA fluorescence was excited with 488 nm line of argon ion laser, and the emitted fluorescence was measured at 515 nm. A time-course software was used to capture the cells images at 2 s intervals (xyt) in the Live Data Mode acquisition at 1024 Â 1024 pixels, at 700 Hz. Using the LSCM computer software, the intensity of the intracellular maximum and minimum fluorescence was measured in the smooth muscle sliced regions. The initial fluorescence intensity value was obtained at t = 0 and was designated F 0 . The final fluorescence intensity value was achieved after stimulation with DCBPY (10 lmol/L), SNP (0.1 lmol/L), or NITRITE (300 lmol/L), and it was named F. In this way, the percentage of the difference in fluorescence intensity (%DFI), which reflects a reduction in [Ca 2+ ]c and a rise in [NO]c in smooth muscle cells, was calculated for each protocol in relation to F 0 (100%), by means of the following formula.
Statistical analysis
Data are expressed as mean ± S.E.M. In each set of experiments, n indicates the number of rats studied. Statistical analysis of the results was performed by using GraphPad Prism version 3.0. Statistical significance was tested by one-way ANOVA (post hoc test: Newman-Keuls). Values of P < 0.05 were considered significant.
Drugs and chemicals
Acetylcholine, phenylephrine, NaNO 2 , TEA, ODQ, DAF-2/DA, and Fluo-3AM were purchased from Sigma-Aldrich (St.Louis, MO, USA).
Results
Chemical studies for the compound DCBPY
The ultraviolet-visible (UV-Vis) spectra revealed that the compound DCBPY can assume different configurations, which are pH-dependent, as depicted in Fig. 1B-D Fig. 1B ). This change was also followed by fourier transform infrared spectroscopy (FTIR) spectrum where a band at 1930 cm À1 attributed to NO coordinated to ruthenium (m NO ) disappeared completely in basic medium and appeared again in acidic medium (data not supplied).
At pH 5.4 and 37°C, the Ru-NO + configuration of the DCBPY complex is not modified over the studied period (Fig. 1C) . However, at pH 9.4 and 37°C the compound is converted to the Ru-NO À 2 configuration, which is not altered up to 60 min (Fig. 1D) .
Vascular reactivity studies
The new DCBPY complex induces relaxation of the aortic rings in a concentration-dependent way, in denuded aortas pre -contracted with phenylephrine (Fig. 2) . The potency of SNP (pD 2 : 8.87 ± 0.10, P < 0.001, n = 8) to elicit relaxation is higher than that of DCBPY (pD 2 : 5.71 ± 0.06, n = 9), whereas there are no differences between SNP (101.5 ± 1.3%) and DCBPY (106.1 ± 1.7%) with respect to the maximum relaxation (Fig. 2) .
The DCBPY complex acquires different configurations at different pH values, as demonstrated in Fig. 1 . Therefore a comparison of these different configurations shows that the compound solubilized at pH 7.4 (pD 2 : 5.71 ± 0.06, n = 9) presents similar potency of relaxation compared with the compound prepared at pH 9.4 (pD 2 :
5.66 ± 0.02, n = 9). However, the potency of the compound is higher at pH 5.4 (pD 2 : 5.91 ± 0.06; n = 10, P < 0.01) compared with pH 7.4 (pD 2 : 5.71 ± 0.06, P < 0.01, n = 9) and pH 9.4 (pD 2 : 5.66 ± 0.02, P < 0.01, n = 9) (Fig. 3) . A control of the acid and basic phosphate buffer solutions employed in the preparation of the drug was carried out, and it was observed that these solutions do not alter the vascular tone. In addition, there are no differences in the maximum relaxant effect induced by the compound at pH 5.4 (104.3 ± 1.0%, n = 10), 7.4 (103.1 ± 1.2%, n = 9) and 9.4 (100.1 ± 1.8%; n = 9) (Fig. 3) .
The complex DCBPY is more potent (pD 2 : 5.71 ± 0.06, n = 9) than NITRITE (pD 2 : 4.55 ± 0.09, n = 10, P < 0.001) as far as the relaxation of aortic rings is concerned (see Fig. 4 ). The relaxation elicited by DCBPY is inhibited by the extracellular NO scavenger oxyhemoglobin (ME from 103.1 ± 1.2%, n = 9, to 14.1 ± 1.3%, n = 5, P < 0.001) and by the (NO Å ) species scavenger hydroxocobalamin (ME from 103.1 ± 1.2%, n = 9, to 14.2 ± 2.1%, n = 5, P < 0.001) (Fig. 5) . On the other hand, the NO À scavenger L-cysteine decreases the potency of DCBPY (pD 2 : 5.03 ± 0.09, P < 0.01, n = 6), but it does not change the maximum relaxant effect (105.6 ± 19.0%; n = 6) (Fig. 5) .
Inhibition of the enzyme guanylyl cyclase with ODQ blocks the relaxation induced by DCBPY (ME from 103.1 ± 1.2%, n = 9, to 11.7 ± 1.5%, n = 8, P < 0.001) (Fig. 6) . The non-selective K + channels blocker TEA lowers the potency of DCBPY (pD 2 : 5.33 ± 0.05, n = 7, P < 0.05), without alterations in the maximum relaxant effect (98.5 ± 2.5%, n = 7) (Fig. 6 ). ]c can be verified by fading of the intensity of the red color after addition of DCBPY, as shown in Fig. 7 . In comparison, the decrease in [Ca 2+ ]c in smooth muscle cells is greater for DCBPY (%DIF: À28.5 ± 1.5%; p < 0.001, n = 4) and SNP (%DIF: À25,30 ± 1,00%; p < 0.001, n = 3) as compared to NITRITE (%DIF: À13.47 ± 0.27%; n = 5) (Fig. 8) .
Confocal microscopy
Regarding the effect of released NO and the enhancement in [NO]c, the compound DCBPY boosts the [NO]c in smooth muscle cells, which can be seen from the increase in the intensity of the red color after addition of DCBPY (Fig. 8) . In comparison, the rise in [NO]c is more pronounced for DCBPY (%DIF: 19.8 ± 1.8%, n = 5, p < 0.001) and SNP (%DIF: 20.1 ± 3.0, n = 5, p < 0.01) compared with NITRITE (%DIF: 13.1 ± 1.1, n = 4) (Fig. 9 ).
Discussion
The main finding of this study is that in its stable configuration (Ru-NO 2 (Cl)(NO)] presents similar characteristics to those of other ruthenium compounds described previously [30] [31] [32] .
When it comes to inducing relaxation of contracted aortas, the stable Ru-NO À 2 configuration from DCBPY is less potent than SNP. Similar results have been achieved for other ruthenium compounds that elicit vascular relaxation by NO release [16, 23] . The unstable Ru-NO configuration is more potent in terms of prompting vascular relaxation compared with Ru-NO À 2 . These results could suggest that the generation of NO Å is higher in the case of the Ru-NO + configuration, compared with Ru-NO À 2 . Also, it could be hypothesized that the Ru-NO À 2 configuration behaves as a nitrite donor, considering that nitrite is less potent than NO Å when induction of vascular relaxation is concerned [33] [34] [35] . In order to verify this hypothesis, a relaxation curve was constructed for NI-TRITE, which gave evidence that the DCBPY complex in the Ru-NO À 2 configuration elicited more potent relaxation compared with NITRITE. Therefore, our data indicate that the DCBPY complex in the Ru-NO À 2 configuration is an NO generator instead of a nitrite donor. Several mechanisms for in vivo conversion of NO À 2 to NO have been identified including non-enzymatic disproportionation at low pH [24] , enzymatic conversion by xanthine oxidoreductase [36] and reduction process by deoxyhemoglobin [26] , myoglobin [27] , among others. Thus, stable ruthenium compounds can induce vascular relaxation by conversion of nitrite to NO.
In this study and in previous works, it has been demonstrated that NO can be generated by NO À 2 coordinated to ruthenium in physiological conditions [22, 23] , thus supporting our hypothesis that the stable Ru-NO À 2 configuration of DCBPY is an NO generator. However, the mechanism of nitrite conversion to NO need to be investigated to nitrite coordinates to ruthenium.
As for aortas incubated with sGC inhibitor (ODQ), it was observed that the relaxation induced by DCBPY is completely dependent on sGC activation, suggesting that the compound DCBPY (Ru-NO À 2 ) generates NO. NO can promote vascular relaxation by different mechanisms, which are either NO-cGMP dependent or NOcGMP independent. The main mechanism of NO with respect to induction of relaxation involves activation of sGC, which catalyzes the conversion of GTP into cGMP [37] . Acting as a second messenger, cGMP activates a family of serine/threonine protein kinases called cGMP-dependent protein kinases (PKG), which in turn induces relaxation by decreasing [Ca 2+ ]c and Ca 2+ desensitization of the actin-myosin contractile system [38] . In addition, other molecular targets have been described to participate in the cGMP pathway, including the activation of potassium channels [39, 40] . The NO cGMP-independent mechanisms have been reported in a number of studies, including those mentioning the direct activation of K + channels [5, 6] .
Potassium channels (K + channels) play an important role in the regulation of the vascular tone. Indeed, its activity is the main determinant of membrane potential [40] . 
. Using a selective scavenger for the radicalar form (hydroxocobalamin) and for the nitroxyl ion (L-cysteine) [8, 41] it was verified that the compound DCBPY generates the NO Å and NO À forms. However, our data suggest that NO Å is mainly generated by DCBPY. The extracellular and non selective NO scavenger oxyhemoglobin [43] abolishes relaxation induced by NO, evidencing that the compound DCBPY generates NO in the extracellular medium. The reaction between NO and oxyhemoglobin is very fast, which does not allow for detection of the biological effect due to NO [44] , which can explain this result.
Some authors have shown that different NO forms can have distinct actions. Dierks & Burstyn [42] demonstrated that NO Å is the only nitrogen monoxide redox form capable of activating sGC and inducing vascular relaxation. Irvine et al. [41] ]c. Considering that the concentration that induced the maximum relaxant effect on vascular reactivity was used for our experiments, we had expected to obtain the same magnitude of effect on the lowering of [Ca 2+ ]c. Taken together, these results suggest that part of the effect of NITRITE on vascular relaxation is due to an independent mechanism for [Ca
2+
]c reduction, which could take place via Ca 2+ desensitization of the actinmyosin contractile system. In conclusion, our results demonstrate that the compound DCBPY (Ru-NO ⁄⁄⁄ indicates significant difference (P < 0.001) in %DFI value for DCBPY vs. NITRITE.
⁄⁄ indicates significant difference (P < 0.01) for SNP vs. NITRITE.
